Stockscreener 앱 받기
17.77
3.27%
-0.60
Arvinas Inc 주식(ARVN)의 최신 뉴스
Arvinas (ARVN) Expected to Announce Earnings on Tuesday - MarketBeat
Arvinas (NASDAQ:ARVN) shareholders have endured a 72% loss from investing in the stock three years ago - Yahoo Finance
Arvinas (ARVN) to Release Quarterly Earnings on Tuesday - MarketBeat
Arvinas (NASDAQ:ARVN) Shares Up 7.4%Time to Buy? - MarketBeat
Arvinas, Inc. (NASDAQ:ARVN) Sees Significant Growth in Short Interest - MarketBeat
Arvinas Operations describes new DGK-α inhibitors - BioWorld Online
Equities Analysts Offer Predictions for Arvinas Q3 Earnings - MarketBeat
Wedbush Estimates Arvinas' Q1 Earnings (NASDAQ:ARVN) - MarketBeat
Earnings call transcript: Arvinas Q4 2024 surpasses EPS forecast, stock rises - Investing.com Nigeria
Q1 Earnings Forecast for Arvinas Issued By Leerink Partnrs - MarketBeat
Arvinas, Inc. (NASDAQ:ARVN) Given Average Recommendation of "Buy" by Analysts - MarketBeat
Oppenheimer Forecasts Strong Price Appreciation for Arvinas (NASDAQ:ARVN) Stock - MarketBeat
Arvinas (NASDAQ:ARVN) Receives Buy Rating from Guggenheim - MarketBeat
Analysts Offer Predictions for Arvinas FY2029 Earnings - MarketBeat
Arvinas (NASDAQ:ARVN) Stock Price Up 5% Following Better-Than-Expected Earnings - MarketBeat
Arvinas (NASDAQ:ARVN) Given "Outperform" Rating at BMO Capital Markets - MarketBeat
Stifel Nicolaus Has Lowered Expectations for Arvinas (NASDAQ:ARVN) Stock Price - MarketBeat
Wedbush Reiterates Outperform Rating for Arvinas (NASDAQ:ARVN) - MarketBeat
How the (ARVN) price action is used to our Advantage - Stock Traders Daily
Arvinas anticipates Phase 3 topline results for vepdegestrant in Q1 2025 with commercial preparations underway - MSN
Arvinas (NASDAQ:ARVN) Posts Quarterly Earnings Results, Beats Estimates By $0.44 EPS - MarketBeat
How Much Upside is Left in Arvinas (ARVN)? Wall Street Analysts Think 235.09% - MSN
All You Need to Know About Arvinas (ARVN) Rating Upgrade to Buy - MSN
Arvinas Holding: Positive Earnings Call Highlights Growth - TipRanks
Q1 Earnings Estimate for Arvinas Issued By Leerink Partnrs - MarketBeat
Arvinas, Inc. (NASDAQ:ARVN) Q4 2024 Earnings Call Transcript - MSN
Arvinas Holding Faces Legal Risks Amid Stock Price Volatility - MSN
These Analysts Revise Their Forecasts On Arvinas After Q4 Results - Benzinga
Snowflake To Rally Around 9%? Here Are 10 Top Analyst Forecasts For Wednesday - Benzinga
Oppenheimer Adjusts Price Target on Arvinas to $45 From $40, Keeps Outperform Rating - Marketscreener.com
Arvinas Holding Company Receives ‘Buy’ Rating: Promising Clinical Advances and Strategic Pipeline Developments - TipRanks
Arvinas, Inc. (ARVN) Reports Q4 Loss, Misses Revenue Estimates - MSN
Arvinas Inc (ARVN) Q4 2024 Earnings Call Highlights: Strong Financial Position and Promising ... By GuruFocus - Investing.com Canada
Arvinas (ARVN) to Release Earnings on Tuesday - MarketBeat
Arvinas Inc (ARVN) Q4 2024 Earnings Call Highlights: Strong Financial Position and Promising ... - Yahoo Finance
Arvinas Reports 2024 Financial Results and Pipeline Progress - TipRanks
Arvinas Inc. (ARVN) reports earnings - Quartz
ARVINAS, INC. SEC 10-K Report - TradingView
Arvinas Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update - GlobeNewswire
0.27%
3.05%
자본화:
|
볼륨(24시간):